Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Israel Ramos
Observed names:
I Ramos,
I. Ramos
Institutions:
Institute for Research in Biomedicine,
Barcelona Institute of Science and Technology,
Stanford Medicine,
Stanford University
Observed institutions:
Almirall (Spain),
Institute for Research in Biomedicine,
Barcelona Institute of Science and Technology,
Stanford Medicine,
Universidade de Vigo,
Stanford University
show all 6
OpenAlex ID:
A5038357320
Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
2009
·
Amadeu Gavaldà
, Montserrat Miralpeix
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
134
Discovery of Novel Quaternary Ammonium Derivatives of (3R)-Quinuclidinol Esters as Potent and Long-Acting Muscarinic Antagonists with Potential for Minimal Systemic Exposure after Inhaled Administration: Identification of (3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane Bromide (Aclidinium Bromide)
2009
·
María Prat
, Dolors Fernández
, et al.
·
Journal of Medicinal Chemistry
·
79
Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: In vitro plasma inactivation and pharmacological activity of its main metabolites
2010
·
Sonia Sentellas
, Israel Ramos
, et al.
·
European Journal of Pharmaceutical Sciences
·
73
Pharmacological Characterization of Abediterol, a Novel Inhaled β2-Adrenoceptor Agonist with Long Duration of Action and a Favorable Safety Profile in Preclinical Models
2012
·
Mònica Aparici
, Mireia Gómez-Angelats
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
60
Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation
2015
·
A. Planagumà
, T. Domènech
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
52
The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide
2014
·
Amadeu Gavaldà
, Israel Ramos
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
51
Extracellular polysaccharides production by Arthrobacter viscosus
2003
·
Elena López
, Israel Ramos
, et al.
·
Journal of Food Engineering
·
33
Lack of activity of 15-epi-lipoxin A4 on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function
2013
·
A Planagumà
, T Domenech
, et al.
·
Clinical & Experimental Immunology
·
26
Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M3 Receptor Antagonist/β2-Adrenoceptor Agonist Molecule with Long-Lasting Effects and Favorable Safety Profile
2019
·
Mònica Aparici
, Carla Carcasona
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
23
PDF
In vitro and in vivo preclinical profile of abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, compared with indacaterol, olodaterol and vilanterol
2015
·
Mònica Aparici
, Amadeu Gavaldà
, et al.
·
European Journal of Pharmacology
·
23
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists
2011
·
Maria Prat
, María Antonia Buil
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
23
Bispecific antibodies targeting the N-terminal and receptor binding domains potently neutralize SARS-CoV-2 variants of concern
2025
·
Adonis A. Rubio
, Viren A. Baharani
, et al.
·
Science Translational Medicine
·
21
PDF
Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist /β 2 -adrenoceptor agonist (MABA) molecule
2017
·
Mònica Aparici
, Carla Carcasona
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
20
Abediterol (LAS100977), an inhaled long-acting β 2 -adrenoceptor agonist, has a fast association rate and long residence time at receptor
2017
·
Israel Ramos
, Mònica Aparici
, et al.
·
European Journal of Pharmacology
·
17
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists
2015
·
Maria Prat
, María Antonia Buil
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
16
New Potent Inhibitor of Transforming Growth Factor-Beta (TGFβ) Signaling that is Efficacious against Microsatellite Stable Colorectal Cancer Metastasis in Combination with Immune Checkpoint Therapy in Mice
2024
·
Daniele V. F. Tauriello
, Elena Sancho
, et al.
·
ACS Pharmacology & Translational Science
·
8
Abediterol, a novel long-acting inhaled β2-agonist, has a fast association rate and long residence time at human β2 receptors
2014
·
Montserrat Miralpeix
, María Letosa
, et al.
·
European Respiratory Journal
·
2
In vitro pharmacological characterization of two novel dual-acting MABA compounds (LAS190792 and LAS191351)
2014
·
Montserrat Miralpeix
, Carla Carcasona
, et al.
·
European Respiratory Journal
·
1
Structure-guided vaccination elicits broadly neutralizing antibodies targeting the HIV-1 silent face
2026
·
Joshua J. Carter
, Maria B. Palacio
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Phenotypic AI-based design of cell-specific small molecule cytotoxics
2026
·
Gema Rojas-Granado
, Marta Sánchez-Soto
, et al.
·
Communications Chemistry
PDF
BPS2026 – Structural insights into germline antibody intermediates guide HIV-1 immunogen design
2026
·
Okikiola Morenike Olajide
, Josh James Carter
, et al.
·
Biophysical Journal
Novel oral voltage-gated sodium channel (Nav) inhibitors inhibit capsaicin induced cough in conscious guinea pigs
2015
·
Monica Aparici
, Jorge De Alba
, et al.
·
European Respiratory Journal
Abediterol has higher β2-receptor affinity and in vitro bronchodilatory potency than other long-acting β2-agonists, with good selectivity
2014
·
Montserrat Miralpeix
, Mónica Aparici
, et al.
·
European Respiratory Journal
In vitro pharmacological characterization of two novel dual-acting MABA compounds (LAS190792 and LAS191351)
2014
·
Montserrat Miralpeix
, Carla Carcasona
, et al.
·
European Respiratory Journal
Abediterol has higher β 2 -receptor affinity and in vitro bronchodilatory potency than other long-acting β 2 -agonists, with good selectivity
2014
·
Montserrat Miralpeix
, Mònica Aparici
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
26
Citation count:
662
H-index:
15
I10-index:
15
Year
Topic
Type